NCCN Webinar: Treatment Strategies for Mesothelioma
Program Overview
Mesothelioma is a rare cancer with a high mortality. It is critical for clinicians to be aware of the current standard of care for the management of mesothelioma, to optimize patient quality of life and clinical outcomes.
This webinar will educate participants on the risk factors and symptoms for mesothelioma, the pathologic subtypes and serum markers that are associated with the diagnosis of mesothelioma, and will provide examples of current treatment options for patients with mesothelioma based on stage of disease and other patient characteristics.
Presenters:
Thomas A. D’Amico, MD
Duke Comprehensive Cancer Center
Lee M. Krug, MD
Memorial Sloan-Kettering Cancer Center
Webinar Schedule*:
* Tuesday, October 19, 2010 • 12:00 – 1:00 PM EDT
* Tuesday, November 2, 2010 • 10:00 – 11:00 AM EDT
* Tuesday, November 16, 2010 • 2:00 – 3:00 PM EST
* Tuesday, December 7, 2010 • 12:00 – 1:00 PM EST
*Please note: each scheduled webinar will include the same content, individuals only need to register for one session.
Educational Objectives:
* List the risk factors and symptoms for mesothelioma.
* Describe the pathologic subtypes and serum markers that are associated with the diagnosis of mesothelioma.
* Provide examples of current treatment options for patients with mesothelioma based on stage of disease and other patient characteristics.
Intended Audience:
This educational program is designed to meet the educational needs of oncologists, nurses, and other health care professionals who manage patients with cancer.
Registration:
There is no fee for this educational webinar. If cancellation is necessary, please notify NCCN.
Accreditation:
Physicians
The National Comprehensive Cancer Network (NCCN) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
NCCN designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Nurses
This activity is approved for 1.0 contact hour. National Comprehensive Cancer Network is an approved provider of continuing nursing education by PA State Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.
Approval as a provider refers to recognition of educational activities only and does not imply ANCC Commission on Accreditation or PA Nurses approval or endorsement of any product.
Kristina M. Gregory, RN, MSN, OCN, is our nurse planner for this educational activity.
Faculty Disclosure:
All faculty participating in NCCN continuing education activities are expected to disclose any conflict(s) of interest related to the content of their presentation(s) as defined by the ACCME’s and ANCC’s Standards for Commercial Support. All faculty presentations have been reviewed for adherence to the ACCME’s Criterion 7: The provider develops activities/educational interventions independent of commercial interests (SCS 1, 2, and 6) by experts on the topics. Full disclosure of faculty relationships will be made prior to the activity.
Supporters:
This activity is supported by an educational grant from Eli Lilly and Company.
Additional Information Regarding Call-in Numbers for WebEx Sessions
Global call-in numbers
Toll-free dialing restrictions
NCCN Webinar: Treatment Strategies for Mesothelioma
viernes, 24 de septiembre de 2010
Suscribirse a:
Enviar comentarios (Atom)
No hay comentarios:
Publicar un comentario